Abstract:Background MRI is of increasing importance in the diagnostic evaluation of gastrointestinal diseases, with depiction of mucosal enhancement obtained with conventional intravenous contrast. Routine clinical use of contrast agents has been carried out using intravenous injection for mucosal imaging. Contrast agents that specifically target the intestinal mucosa are therefore needed to improve clinical imaging of the mucosal surface. Purpose To synthesize a novel contrast agent for gadopentetic acid (Gd-DTPA)-loaded chitosan nanoparticles and observe the absorption of the nanoparticles in the colon wall of healthy rats by MR imaging in vivo. Material and Methods A contrast agent was successfully synthesized by a modified emulsion coalescence method, and the resulting agents were characterized in detail by dynamic light-scattering spectroscopy and inductively coupled plasma emission spectroscopy. The cytotoxicity of Gd-chitosan nanoparticles was evaluated by an MTT assay. Gadolinium-chitosan (Gd@chitosan) nanoparticles were administered to the colon mucosa of healthy rats by rectal administration, and MRI scans in vivo were carried out with a 3.0 T imaging scanner at various time points. Results The prepared Gd@chitosan nanoparticles were ∼420 nm in diameter with a 74.4% Gd-DTPA content. The MTT assay indicated little cytotoxicity. MRI results showed that nanoparticles can be retained in both the stratum submucosum and epithelial cells of the colon for almost 80 min. Transmission electron microscopy images further revealed that Gd@chitosan nanoparticles were localized inside the mucosal cells or intercellular space, while tissue from Gd-DTPA aqueous solution administration showed nothing. Due to the infusion of Gd@chitosan nanoparticles, the MR signal intensity of colon mucosa increased from about 6% to 35%, and the contrast enhancement was highest at 20 min after administration. Conclusion Gd@chitosan nanoparticles with high Gd-DTPA content were successfully prepared for use as a novel MRI contrast agent. All results indicated that rectally administered Gd@chitosan nanoparticles have the potential for MRI diagnosis of colon mucosal disease.

Gd-DTPA-chitosan Particles As a Magnetic Resonance Contrast Agent for Rat's Intestinal Mucosa Targeted Imaging

Gadolinium-chitosan Nanoparticles As a Novel Contrast Agent for Potential Use in Clinical Bowel-Targeted MRI: a Feasibility Study in Healthy Rats.

In Vivo Imaging of Colon Mucosa Targeted Gadolinium-Loaded Chitosan Particles in Mice with MRI

A Novel Magnetic Contrast Agent for Gastrointestinal Mucosa-Targeted Imaging Through Oral Administration.

Oligoethylenimine-Grafted Chitosan As Enhanced T-1 Contrast Agent for in Vivo Targeted Tumor Mri

Oral Gd-DTPA as a negative gastrointestinal contrast agent in magnetic resonance cholangiopancreatography

Hyaluronic Acid-Chitosan Nanoparticles to Deliver Gd-DTPA for MR Cancer Imaging

Preparation and Animal Experiment of Lymphatic System-Targeted Contrast Agent in Magnetic Resonance Imaging

PEGylated chitosan grafted with polyamidoamine-dendron as tumor-targeted magnetic resonance imaging contrast agent

Preparation and in Vitro Evaluation of a Gadolinium-Containing Vitamin E TPGS Micelle As a Potential Contrast Agent for MR Imaging

Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation

Gadolinium-Loaded Chitosan Nanoparticles As Magnetic Resonance Imaging Contrast Agents for the Diagnosis of Tumor

The primary applications of Gd-DTPA as an oral negative gastrointestinal contrast agent for MRCP

Synthesis of PEGylated BaGdF5 Nanoparticles As Efficient CT/MRI Dual-modal Contrast Agents for Gastrointestinal Tract Imaging

Study of Gd-poly-DTPA-EOEA Contrast Agent Targeted for Lymphatic System in Magnetic Resonance Imaging: Preparation, Characterization and Properties

A novel CT contrast agent for intestinal-targeted imaging through rectal administration

Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.

Development of a Novel MR Colonography via Iron-Based Solid Lipid Nanoparticles

Lectin-Gd-loaded chitosan hydrogel nanoparticles: a new biospecific contrast agent for MRI

Preparation of Targeted Gd3+ Contrast Agent Based on Folate-receptor and Its Relaxation

Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.